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Efficacy and Safety of Balloon Pulmonary Angioplasty for Non-operable Chronic Thromboembolic Pulmonary Hypertension in Comparison to Pulmonary Endarterectomy for Operable Patients Yu Taniguchi 1 , Noriaki Emoto 1 , Hiroto Kinutani 1 , Hiromasa Otake 1 , Toshiro Shinke 1 , Ken-ichi Hirata 1 1 Kobe University Graduate School of Medicine, Kobe-city, Hyogo
Background: Pulmonary thromboendarterectomy (PEA) has been a standard therapy for the treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH), however, up to 40% of patients are considered non-operable due to distal types of thromboembolism or comorbidities, resulting in poor prognosis. Therefore, we performed balloon pulmonary angioplasty (BPA) for non-operable patients, and evaluated the efficacy of BPA in comparison with PEA. Methods: We treated 46 CTEPH patients from November 2001 to May 2013. Operable 21 patients underwent PEA (56.8 AE 14.7 years old, San-Diego class I:9, II:4, III:8, IV:0) and 25 non-operable patients, with mean pulmonary artery pressure (mPAP) ! 25mmHg in spite of under medical therapy, were performed BPA (67.8 AE 10.3 years old, San-Diego class I:0, II:3, III:15, IV:7). BPA was repeated in 1 to 6 sessions to every patient depending on their severity. We evaluated hemodynamics by Swan-Ganz catheter at baseline and post procedure. Results: PEA significantly improved hemodynamics in operable patients (Table) . In non-operable patients, even BPA dramatically improved hemodynamic parameters such as a significant increase in cardiac output (CO) and decrease in mPAP and pulmonary vascular resistance (PVR), which were accompanied with improved 6minute walk distance (6MWD) and WHO-Fc as observed in PEA for operable patients. Reperfusion pulmonary injury occurred in 3 patients (14.3%) after PEA, and in 21 sessions (32.8%) after BPA with 3 sessions required emergent intubation. Two patients (9.5%) died after PEA due to persistent of right heart failure and 1 patient (4.0%) died after BPA due to systemic infection.
Conclusions: BPA could be an effective treatment option for non-operable CTEPH to achieve dramatic improvement of hemodynamic and outcome parameters. The efficacy and safety for non-operable cases were equivalent to those of PEA for operable cases.
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Is fetal aortic valvuloplasty effective to achieve a biventricular circulation after birth?
Carlos Pedra 1 , Simone Pedra 2 , Rodrigo Costa 2 , Marcelo Ribeiro 2 , Fabio Peralta 2 1 Hospital do Coração, São Paulo, Brazil, 2 Hospital do Coração, Sao Paulo, Brazil Background: Critical aortic stenosis (AS) in utero is a severe disease that may evolve to hypoplastic left heart syndrome (HLHS) if not treated. Fetal aortic valvuloplasty (AV) has been performed in selected cases to avert this progression. However, more data is required to assess its impact on achieving a biventricular circulation (BVC), especially in patients with smaller left ventricles (LV). We report the immediate procedural results and the postnatal outcomes up to one year of age of fetuses who underwent AV. Methods: Procedures were performed under spinal maternal block and fetal anesthesia between 23 to 34 weeks gestation through a transabdominal (maternal) and transthoracic (fetus) approach under echo guidance. The LV apex was entered using 17/18 G Chiba needles and the valve was dilated with coronary angioplasty balloons (1-1.2 times the valve annulus). Serial echos were performed pre and post natally. Results: Thirteen fetuses underwent the procedure. Five were severely hydropic, 4 had severe mitral regurgitation and gigantic left atrium (GLA), 3 had hypoplastic LVs (2 severe). Endocardial fibroelastosis was present in all (severe in 6). In all but 1 fetus the valve was successfully crossed and dilated. Satisfactory antegrade flow was observed in 12 cases, aortic insufficiency in 7 and pericardial effusion AE bradycardia in 9 fetuses requiring needle aspiration + atropine. There were no maternal complications. There were 2 early neonatal deaths after premature delivery because of severe hydrops (both with GLA). BVC was achieved in 3 neonates. All required aortic valvuloplasty. Three with smaller LV underwent aortic valvuloplasty + hybrid procedures, with 2 undergoing LV overhaul and a BVC @ 9 months of age. In the other a BVC is still contemplated. One neonate born at another institution died on the first day of life, 3 were managed as univentricular hearts and 1 had comfort care (no LV growth). Conclusions: Fetal aortic valvuloplasty may improve overall neonatal and infancy outcomes. BVC was achieved in 30% of the cases with a chance of improving to a 50% rate. Neonatal outcomes seem to depend on the clinical and anatomical fetal presentation, with hydropic fetuses having worse outcomes. www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 1:00 PM-3:15 PM 
